<%! String[] file_list= new String[4]; String curfile; %> <% file_list[0] = "/corp_flash/banner-1.swf"; file_list[1] = "/corp_flash/banner-2.swf"; file_list[2] = "/corp_flash/banner-3.swf"; file_list[3] = "/corp_flash/banner-4.swf"; %> <%! String GetnewImage() { curfile = file_list[(int)Math.floor(Math.random() * 4) ]; return ""; } %> <%=GetnewImage()%>

 
Happenings

Jubilant Organosys Q4 FY2006 Net Sales up 32%, PAT up 41%
- FY2006 Net Sales up 29%, PAT up 9%
Board declares 125% dividend for the year
Jubilant Organosys' Custom Research & Manufacturing
- order book at US$ 68 million Jubilant Organosys Q3 FY2006 Net Sales up 47%
- Net Profit up 36%
International revenues up 55%
- Pharma & Life Sciences sales up 68%
- Board recommends stock split
Jubilant Organosys Q2 FY2006 Net Sales up 17%
-Net Profit declines 11%
-International revenues up 21%, Pharma & Life Science sales up 22%
Jubilant acquires Clinical Research Organization in USA
Jubilant becomes largest Indian CRO
Jubilant Organosys allots 990,000 shares to General Atlantic
-Funds raised will support global growth initiatives
27th AGM approves Equity placement to General Atlantic, hike in FII limit and stock options for employees
-Jubilant to enhance presence in global pharma market
Jubilant Organosys to raise Rs. 1.09 billion from General Atlantic to support
-Equity placed at Rs 1100 per share
Jubilant Organosys releases Q1 FY2006 results
-Net Sales up 23%
-International revenues up 32%
Jubilant Organosys acquires pharma company in USA

Strengthens presence in high growth opportunities in world’s largest generic pharma market

Jubilant Corporation comprises four profitable sectors of activity - Life Science Products & Speciality Chemicals, Food, Oil & Gas, and Services. A shared vision and common set of values bind them. Over the years we have created globally sustainable strengths, and a global presence in the chemicals sector, while the new services sector has seen us gather tremendous experience and grow. Our focus on servicing customers across sixty countries, building partnerships to create value, and research and development has generated significant stakeholder return. Jubilant Corporation had the revenue of US$615 million in financial year 2004-05 which includes US$ 300 million of the value of transactions handled in india on behalf of principals.


Our Businesses

Life Science Products & Speciality Chemicals

Jubilant Organosys, Jubilant Biosys, Jubilant Chemsys, Jubilant Clinsys, PSI, PSI Supply, Trigen laboratories, Clinsys .

Oil & Gas (E&P)

Jubilant Enpro

Food

Domino's Pizza, Monday To Sunday

Services

Jubilant Enpro: Oil & Gas, Aerospace, Automobile, Power & Infrastructure, Services

Network Programs: Software Solutions

AO Capital Partners: Financial Advisory Services & Fund Management


Our Values
Site Developed by Module One   About Us | Our Businesses | Investors | Media Center | Careers Sitemap | Contact Us | Legal